No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Biotech Royalties
Managing Royalties in Biotech, Pharma, and MedTech
In this episode of The Life Science Rundown podcast, MetaComet president and co-founder David Marlin discusses how biotechnology, pharmaceutical, and medical device firms struggle to manage licensing agreements as they scale. What starts as a simple once-a-year payment can quickly evolve into a tangled web of tiered rates, stacked IP, country-specific rules, and audit requirements.